Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Managing cosmetic regulatory data across the U.S., Canada, and Europe is no longer just a compliance issue. It is a data management challenge that directly impacts consistency, risk, and scalability for cosmetic brands.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
The European cosmetics industry is highly regulated to ensure consumer safety, with claims on products needing to meet six criteria under regulation 655/2013. Authorities monitor compliance, focusing on truthfulness and fairness, to prevent misleading marketing.
The European market lacks investment in SVHC substitution, hindering progress. The Lowell centre recommends building infrastructures, increasing engagement, and enhancing technical capacity to support the analysis of alternatives. Authorities face challenges in identifying, evaluating, and adopting SVHC substitution. ECHA can play a key role in supporting these initiatives. For more information on SVHCs, visit our website.
Comparison of US and EU cosmetic regulations: US focuses on FDA laws like FD&C Act, while EU Regulation 1223/2009 emphasizes safety, good practices, and market surveillance. Labeling requirements differ, with US requiring more detailed information.
ECHA predicts a surge in REACH registrations, with 60,000 dossiers expected for 25,000 substances. Germany leads in registrations, with SMEs taking on more roles. Learn the benefits of being a Lead registrant and the importance of timely registration.
This article provides a comprehensive guide to REACH Authorisation compliance, divided into two parts: a practical checklist for compliance reports and a detailed overview of Authorisation dossiers. It covers key compliance elements, notification requirements, and inspection preparation.
As the REACH regulation does not distinguish between substances in “nano” and “bulk” form, Switzerland has decided to carry out a legislative review in view of REACH 2018. However, the Swiss Federal Office of Health (BAG) is missing various information to carry out this project.
